Search

everythinglearnresearchcommunity

for

Search:↓

Glucocorticoids and thyroid hormones together are essential for fetal fat development.

Derinat helps extend hair growth by reducing harmful molecules in skin cells.

Combining injections with lotion is more effective for hair regrowth in alopecia areata than using the lotion alone.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Cytokine therapy is promising for treating skin conditions like vitiligo and psoriasis.

A 21-day-old baby had a skin rash that didn't improve with cream and wasn't caused by a fungus.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

A new treatment plan helps manage folliculitis decalvans effectively.

A man's rash caused by Finasteride improved after stopping the drug and starting new treatments.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Topical 0.1% tacrolimus improved a rare ear condition in cats.

DCPA is a chronic skin condition affecting the legs, often misdiagnosed, and needs more research for better understanding and treatment.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Oral calcitriol helped improve scleroderma and hair regrowth in a young woman.

Topical metformin gel is as effective and safe as steroids for treating alopecia areata.

Tretinoin cream successfully treated a woman's skin condition called Fox-Fordyce disease.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Combining laser treatment with steroid cream is more effective for alopecia areata than using the cream alone.

Topical minoxidil showed promise for early male pattern baldness.

Espumil foam base allows easy preparation of skin medications for hairy areas.

Corticosteroids and topical irritants are used to treat alopecia areata.

Remote monitoring of chronic diseases like dermatomyositis is challenging and needs better tools for early detection and patient education.

Steroids may not work well for alopecia areata because of high unoccupied receptors and low thioredoxin levels.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

The combination therapy was effective and well-tolerated, especially in young patients.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.